Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-02
1995-10-10
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548453, A61K 3140, C07D48702
Patent
active
054571219
ABSTRACT:
This invention provides ring-substituted cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles which are selective inhibitors of serotonin reuptake.
REFERENCES:
patent: 4308226 (1981-12-01), Seiler
patent: 4845221 (1989-07-01), Stack et al.
patent: 4880802 (1989-11-01), Schohe et al.
patent: 5026707 (1991-06-01), Nixon et al.
Nichols, et al., J. Med. Chem., 33, 703-710 (1990) Month of publication not provided.
Hibert, et al., Eur. J. Med. Chem., 24, 31-37 (1989) Month of publication not provided.
Singh, Arzneim.-Forsch./Drug Res., 36, 1437-1439 (1986) Month of publication not provided.
Bateman, Br. J. clin. Pharmac., 20, 339-344 (1985) Month of publication not provided.
Arvidsson, et al., J. Med. Chem., 27, 45-51 (1984) Month of publication not provided.
Hacksell, et al., J. Med. Chem., 22, 1469-1475 (1979) Month of publication not provided.
McDermed, et al., J. Med. Chem., 18(4), 362-367 (1975) Month of publication not provided.
Schaus John M.
Titus Robert D.
Boone David E.
Dahling Gerald V.
Eli Lilly and Company
Jones Joseph A.
Shah Mukund J.
LandOfFree
Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2310662